Stock Earnings Selling Buzz: Nurix Therapeutics Inc [NRIX] Chief Financial Officer van Houte Hans sells 5,402 shares of the company Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Leerink Partners analysts initates a Market perform rating for Nurix Therapeutics Inc (NRIX) In a filing, Nurix Therapeutics Inc revealed its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $59598.0
Stock Earnings Nurix Therapeutics Inc (NRIX) may enjoy gains as insiders got busy in the recent days Nurix Therapeutics Inc’s recent filing unveils that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $59598.0
Stock Earnings Sharp decrease in NRIX’s short interest leads to decline in days-to-cover ratio The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or